Clonal hematopoiesis of indeterminate potential: a review of its cardiorenal implications and aging
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfaf055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Abdullah Jalal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Aging, Cardiovascular Diseases, Kidney Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Clonal hematopoiesis of indeterminate potential (CHIP) is a non-malignant state characterized by hematopoietic stem cells exhibiting clonality driven by acquired mutations during aging. Using next-generation sequencing, it has been reported that the prevalence of CHIP increases exponentially with age. Thus far, epigenetic mutations including DNMT3A, TET2 and ASXL1 are the most common mutations identified in driving CHIP. CHIP is considered a pre-malignant state, however with reports of its associations with non-malignant disease states, the clinical impact of CHIP has been of great interest, in particular its effect on the renal and cardiac systems. CHIP has been associated with a higher rate of estimated glomerular filtration rate decline and increased risk of acute kidney injury. CHIP and its driver mutations have also been shown to increase cardiovascular disease and atherosclerosis through various inflammatory pathways. In this review, we discuss the pathophysiology of CHIP through aging, its impact on kidney disease and implications on cardiovascular health. We also compare CHIP to another pre-malignant clonal disorder, monoclonal gammopathy of undetermined significance (MGUS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
- Northwell Health, New Hyde Park. NY and Division of Kidney Diseases and Hypertension, Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.
- Department of Medicine, Division of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Adult Survivorship Program, Dana Farber Cancer Institute, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Kenar D Jhaveri
Zitieren
APA
Jalal, A., Jhaveri, K. D., & Chowdhury, R. B. (2025). Clonal hematopoiesis of indeterminate potential: a review of its cardiorenal implications and aging. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf055
Vancouver
Jalal A, Jhaveri KD, Chowdhury RB. Clonal hematopoiesis of indeterminate potential: a review of its cardiorenal implications and aging. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf055
BibTeX
@article{Jalal2025,
author = {Jalal, Abdullah and Jhaveri, Kenar D and Chowdhury, Raad B},
title = {Clonal hematopoiesis of indeterminate potential: a review of its cardiorenal implications and aging},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfaf055}
}
EUVIMED